Calcium channel blockers

Medicine

Volumn 35, Issue 11, 2007, Pages 599-602

  Buckley, Nick ^a,b   Dawson, Andrew ^a,b   Whyte, Ian ^a,b  

^a The Australian National University   (Australia)

^b NONE

Author keywords

antidotes; calcium channel blockers; cardiotoxicity; poisoning

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ACTIVATED CARBON; ADRENERGIC RECEPTOR STIMULATING AGENT; AMLODIPINE; ANTIDOTE; ATROPINE; BENZOTHIAZEPINE DERIVATIVE; BICARBONATE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALCIUM CHLORIDE; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DOPAMINE; FELODIPINE; GLUCAGON; GLUCOSE; HYPERTENSIVE FACTOR; INSULIN; INTRALIPID; ISOPRENALINE; LACTIC ACID; LERCANIDIPINE; NICARDIPINE; NIFEDIPINE; NIMODIPINE; PHENYLALKYLAMINE; UNINDEXED DRUG; VERAPAMIL;

BLOOD ANALYSIS; BRADYCARDIA; CARDIOPULMONARY BYPASS; CONTROLLED RELEASE FORMULATION; DEATH; DETERIORATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG INTOXICATION; DRUG METABOLISM; DRUG OVERDOSE; ELECTROCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; FIRST PASS EFFECT; FLUID THERAPY; HEART BLOCK; HUMAN; HYPERGLYCEMIA; HYPOTENSION; ILEUS; INTESTINE LAVAGE; LACTIC ACIDOSIS; LETHALITY; LUNG EDEMA; MEDICAL ASSESSMENT; NAUSEA AND VOMITING; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEIZURE; SELF POISONING; SHOCK; TOXICOKINETICS;

EID: 34648863347     PISSN: 13573039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpmed.2007.08.025     Document Type: Review

References (22)

1. Olson K.R., Erdman A.R., Woolf A.D., et al. Calcium channel blocker ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 43 (2005) 797-822
2. Howarth D.M., Dawson A.H., Smith A.J., Buckley N., and Whyte I.M. Calcium channel blocking drug overdose: an Australian series. Hum Exp Toxicol 13 (1994) 161-166
3. Salhanick S.D., and Shannon M.W. Management of calcium channel antagonist overdose. Drug Saf 26 (2003) 65-79
4. Buckley N., Dawson A.H., Howarth D., and Whyte I.M. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium. Med J Aust 158 (1993) 202-204
5. DeWitt C.R., and Waksman J.C. Pharmacology, pathophysiology and management of calcium channel blocker and beta-blocker toxicity. Toxicol Rev 23 (2004) 223-238
6. Luomanmaki K., Tiula E., Kivisto K.T., and Neuvonen P.J. Pharmacokinetics of diltiazem in massive overdose. Ther Drug Monit 19 (1997) 240-242
7. Wilimowska J., Piekoszewski W., Krzyanowska-Kierepka E., and Florek E. Monitoring of verapamil enantiomers concentration in overdose. Clin Toxicol (Phila) 44 (2006) 169-171
8. Sporer K.A., and Manning J.J. Massive ingestion of sustained-release verapamil with a concretion and bowel infarction. Ann Emerg Med 22 (1993) 603-605
9. Pearigen P.D., and Benowitz N.L. Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine. Drug Saf 6 (1991) 408-430
10. Achike F.I., and Dai S. Influence of pH changes on the actions of verapamil on cardiac excitation-contraction coupling. Eur J Pharmacol 196 (1991) 77-83
11. Tanen D.A., Ruha A.M., Curry S.C., Graeme K.A., and Reagan C.G. Hypertonic sodium bicarbonate is effective in the acute management of verapamil toxicity in a swine model. Ann Emerg Med 36 (2000) 547-553
12. Stone C.K., May W.A., and Carroll R. Treatment of verapamil overdose with glucagon in dogs. Ann Emerg Med 25 (1995) 369-374
13. Lheureux P.E., Zahir S., Gris M., Derrey A.S., and Penaloza A. Bench-to-bedside review: hyperinsulinaemia/euglycaemia therapy in the management of overdose of calcium-channel blockers. Crit Care 10 (2006) 212
14. Yuan T.H., Kerns W.P., Tomaszewski C.A., Ford M.D., and Kline J.A. Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning. J Toxicol Clin Toxicol 37 (1999) 463-474
15. Ramoska E.A., Spiller H.A., Winter M., and Borys D. A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. Ann Emerg Med 22 (1993) 196-200
16. Bania T.C., Chu J., Perez E., Su M., and Hahn I.H. Hemodynamic effects of intravenous fat emulsion in an animal model of severe verapamil toxicity resuscitated with atropine, calcium, and saline. Acad Emerg Med 14 (2007) 105-111
17. Tebbutt S., Harvey M., Nicholson T., and Cave G. Intralipid prolongs survival in a rat model of verapamil toxicity. Acad Emerg Med 13 (2006) 134-139
18. Bania T.C., Chu J., Almond G., and Perez E. Dose-dependent hemodynamic effect of digoxin therapy in severe verapamil toxicity. Acad Emerg Med 11 (2004) 221-227
19. Tuncok Y., Apaydin S., Gelal A., Ates M., and Guven H. The effects of 4-aminopyridine and Bay K 8644 on verapamil-induced cardiovascular toxicity in anesthetized rats. J Toxicol Clin Toxicol 36 (1998) 301-307
20. Ishii K., Taira N., and Yanagisawa T. Differential antagonism by Bay K 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle. Br J Pharmacol 84 (1985) 577-584
21. Maclaren G., Butt W., Cameron P., Preovolos A., McEgan R., and Marasco S. Treatment of polypharmacy overdose with multimodality extracorporeal life support. Anaesth Intensive Care 33 (2005) 120-123
22. Holzer M., Sterz F., Schoerkhuber W., et al. Successful resuscitation of a verapamil-intoxicated patient with percutaneous cardiopulmonary bypass. Crit Care Med 27 (1999) 2818-2823